Public Health

Above the Law founder David Lat is being discharged after COVID-19 battle

  • Print

David Lat

Photo courtesy of David Lat.

Above the Law founder David Lat tweeted Wednesday he is being discharged from NYU Langone Hospital where he was treated for COVID-19.

“Not an #AprilFoolsDay Joke,” he tweeted. “After 17 days at @nyulangone, including 6 days on a ventilator, I’m being discharged!”

Lat, now a legal recruiter, described himself as “a grateful patient” of the Manhattan hospital and thanked the people there who had saved his life.

Lat tweeted the hospital had contacted his husband for permission to be part of a special drug trial. The hospital had said Lat was eligible because he was on a ventilator and experiencing life-threatening lung failure.

Lat also learned a major newspaper was interviewing prominent lawyers and journalists for his obituary.

Lat listed the drugs he received in a Tuesday interview with the New York Law Journal conducted by direct messaging on Twitter.

He said he received IL-6 inhibitors called Kevzara, Tocilizumab and Clazakizumab; the antimalarial drug hydroxychloroquine combined with the antibiotic azithromycin; and an antiviral called Remdesivir.

IL-6 inhibitors target interleukin-6, a protein that plays a role in inflammation. Remdesivir is an experimental antiviral drug. Hydroxychloroquine may interfere with the ability of the novel coronavirus to enter cells, the Associated Press has reported.

“In terms of what did the trick, the doctors can’t say,” Lat told the New York Law Journal.

Lat told the New York Law Journal he was looking forward to reuniting with his husband, Zachary Baron Shemtob, their young son, and his parents. He also was looking forward to getting cleaned up.

“I haven’t shaved or showered since being admitted,” he said.

See also: “Above the Law founder David Lat is transferred out of ICU and taken off ventilator” “Above the Law founder David Lat is put on a ventilator after COVID-19 diagnosis”

Give us feedback, share a story tip or update, or report an error.